Last reviewed · How we verify

NCT07119632

Study of Medicine Stick Therapy Combined With Repeated Urotong Herapy on Lower Limb Dysfunction in Stroke Patients

Not yet recruiting NA Last updated 13 August 2025
What this trial tests

NA trial testing RFE therapy in Stroke in 7 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
31 December 2026
31 December 2027

Quick facts

Lead sponsorJiangen Ye
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment7
Start date1 September 2025
Primary completion31 December 2026
Estimated completion31 December 2027

Drugs / interventions tested

Conditions studied

Sponsor

Jiangen Ye

Who can join

Adults 18 to 65, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At present, domestic scholars have applied medicine stick therapy and repetitive facial exercise (RFE) to the rehabilitation treatment of stroke patients, but there are few relevant literature reports on medicine stick therapy combined with RFE and show the differences in the effects of the two different treatment methods. To this end, this study intends to follow up the effects and effects of drug stick therapy and its combined effect with RFE on the recovery of lower limb motor function in patients after stroke, and follow up the patients' limb motor function, daily life activity ability, quality of life, balance function, etc.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07119632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing